BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Closed|| Long (1Y)
CLSA maintains buy on Dr. Reddy's Laboratories
See Dr Reddy's Lab shares to double in 3
years. Stock trades in line with 10-year-average price earnings multiples.
Earnings growth is likely to be weak in the first half of FY17. Expect
re-rating as earnings growth recovers.